CPhI Frankfurt (previously called CPhI Worldwide) — the world’s largest pharma event — returns to Germany in 2022
It remains the go-to event for global pharma, attracting industry wide participation and making this event the best place to source, network and collaborate.
The 2022 edition brings a raft of exciting changes – including a full schedule of onsite content and in-person sessions for the first time since 2019 – with event numbers expected to meet or exceed pre-pandemic levels as the pharma community turns out again en masse.
The 3 day exhibition and in-person conference will be hosted at Messe Frankfurt, Germany, 1-3 November 2022, and will run in hybrid form – fusing the best elements of the traditional show with interactive online features to help attendees maximise their CPhI experience.
Extending the value delivered, CPhI will open its networking and learning platform on 28 Sep 2022 with the "Connect to Frankfurt" digital platform that will begin the countdown to CPhI Frankfurt. Connect to Frankfurt will feature more than 40 on-demand session covering topics from all aspect of the pharma supply chain.
One significant change, which will be immediately clear, is that the event has been rebranded as CPhI Frankfurt and the onsite experience enhanced for attendees’ ease of navigation. For example, the collocated events have been replaced by descriptively named zones for packaging, outsourcing, machinery and more.
“One of the reasons behind the new identity is that we wanted to deliver the smoothest possible onsite experience so that attendees and exhibitors can concentrate on maximising opportunities. Everything we have done is to help the industry to match with exactly the right partners and to be able to do this more quickly,” said Orhan Caglayan, Group Director CPhI Frankfurt.
Who attends: It’s truly the heart of pharma with participants from more than 145 countries; with 78% having purchasing responsibility and 47% from the C-suite.
CPhI Frankfurt has been designed to empower attendees to more connections and make them count, with a full platform of enhancing digital tools to use pre-event.
Who exhibits: CPhI Frankfurt is the beating heart of the entire global pharma supply chain – with everything from ingredients and finished dosage drugs to machinery, outsourcing providers, packaging and even bioprocessing at BioProduction.
CPhI Awards 2022: Held on 1 Nov 2022, the CPhI Awards will feature a welcome reception and ceremony to celebrate the industry’s achievements and brightest stars – with categories spanning a total of 10 awards.
Event Opening Hours: 10:30 to 18:30
Early Access: 09:30 to 18:30
VIP Access: 09:30 to 18:30
To register kindly click here.
Please note free attendee registration for the event ends on 4 September.
Connect to Frankfurt: Take the first digital step on your journey to CPhI Frankfurt.
Connect to Frankfurt marks the launch of the digital platform – a companion to CPhI Frankfurt – the online meeting place to connect with the entire supply chain. The platform empowers visitors to source suppliers, browse the exhibitors list and discover the full content agenda.
Log-in to Connect to Frankfurt to discover even more industry insights and unlock endless opportunities to enhance your pharma knowledge.
Connect to Frankfurt gives companies a head start on finding the right partners, the ability to nurturing business relationships in advance and spark powerful new partnerships. Attendees can make contact online, pre-vet partners and then schedule in person meetings at the event.
The CPhI Frankfurt app provides both attendees and exhibitors with a timetable of each day’s activities, a full list of exhibitors and onsite navigation (including hall locations).
The CPhI Frankfurt content experience begins online on 28 September 2022, with Connect to Frankfurt. Highlights include a "trends outlook" session hosted by leading marketing intelligence companies (including IQVIA and Accenture), the CPHI Learning Labs – with insights from leading pharma companies on new products & solutions – and an overview of the German pharma market and the CPhI Award finalists.
The on-demand webinars will span more than 40 sessions and cover Ingredients & Formulation, Outsourcing and Manufacturing, Packaging & Drug Delivery, Supply Chain & Finished Products and Digitalisation.
A session on Sustainability Strategies in the Life Sciences Industry will be hosted by Accenture AG, as well as analysis from GlobalData exploring Predictions for Future Drugs.
The conference agenda, the largest ever put together by CPhI, will span some five tracks across 3 days in the main Conference theatre, with an additional theatre dedicated to Product Innovation and Sustainability.
Reflecting the hottest trends in the industry and attendees’ interest, the tracks cover: Ingredients and Formulation (Track 1), Future Therapies (Track 2), Digital (Track 3), Manufacturing Excellence (Track 4), and Patient Centricity (Track 5).
The opening day keynote explores the glut of recent research into psychedelic therapies to treat an array of mental health issues from depression to anxiety and post-traumatic stress. David Erritzoe, Clinical Director and Deputy Head at the Centre for Psychedelic Research presents an Introduction of Psychedelic Therapies into Mental Health - Current Status and Future Perspective.
Each of the five tracks will feature a keynote address, panel discussions and presentations, with the second hall focused on exhibitor product innovations – including biologicals – and industry wide efforts to improve sustainability with best practice case studies.
Day 1 includes tracks 1 and 2 in the morning and afternoon respectively, with a morning keynote on Psychedelic Therapy research and the afternoon’s presented by Thermo Fisher.
The Ingredients and Formulations track will see Lonza espouse the benefits of enteric softgels. Precision NanoSystems ULC discuss the use of LNP (lipid nano particles) for genomic medicines and Iain Moore, President, EXCiPACT will present the association’s latest developments - including an update on the extension of its certification programme for Pharmaceutical Auxiliary Materials (PAMS).
In the afternoon, the future therapies track will see PharmaVentures explore Transactional Strategies to Access Future Therapeutics and Technologies, a session on advanced genetic therapies by Citeline, and a review of the regulatory pathway for mRNA therapies from Genome Lawyers.
The second day of content begins with a keynote address from Craig Lipset, Founder, Clinical Innovation Partners & Co-Chair, Decentralised Trials and Research Alliance, with the afternoon keynote from CDMO, Pfizer CentreOne.
The digital track, held in the morning, will explore the digital transformation and the industry’s journey toward Pharma 4.0, McKinsey & Company discuss Digital Health Value Pools and Digital Health Reimbursement, and there’s a special roundtable on What it Takes to Enable Health Data Collaboration Across Organisations and Industries.
The afternoon’s track is dedicated to Manufacturing Excellence and will see sessions on Accelerating Innovation and Development of Future Biomanufacturing Processes, the United States Pharmacopeial Convention (USP) discuss the Paradigm Shift to Continuous Flow Processes, and Zaphyr Pharmaceuticals on best practices for Scale-Up & Tech Transfer.
The final morning of the show is focussed on Patient Centricity and will open with a keynote address from the National Coalition of Organisations for Patients with Chronic Conditions of Romania (COPAC), & the European Patient's Forum Board.
This will be followed by a roundtable on Latest Trends in Consumer Health, a session from On Demand manufacturing covering Supply Chain Resiliency & Patient-Ready Medicine Delivery, and closes with Deloitte Consulting analysing the use of AI for Advanced Digital Customer Segmentation.
Day 1: The Product Innovation sessions will discuss Lipid-Based Excipients (LBEs) as a Solution to Poor Solubility, a session from Samsung Biologics and the design of new elastomer formulation for lyophilised applications in the morning. In the afternoon there will be a review of Taking Secondary Packaging for Vials to the Next Level, as well as sessions from BD, on nasal biologics delivery, primary closure systems, and an ESG Framework case study.
Day 2: Is dedicated to sustainability approaches, process improvements and green manufacturing – with case studies from Indena and Aspen, an insights session from IQVIA and a supply chain perspective on green manufacturing from Boehringer Ingelheim in the morning.
In the afternoon, the debate switches to the implications of sustainability for excipient manufacturers and users, followed by a presentation from Bachem and then Rx-360, with the USP exploring strategies to achieve sustainable pharmaceutical manufacturing. The sustainability track closes with a fireside chat on ‘sustainable access to medicines and equipment’.
Running alongside CPhI Frankfurt content will be 3 days of biologics sessions curated by the team at BioProduction. Highlights include session exploring the Digitalisation of Biomanufacturing – How to Obtain Better Data, Robotic Facility for Bioprocess Development, Digital Twin-Assisted Manufacturing, The Use of Semi-Automation During Cell Line Development and Bioreactor Automation.
In total BioProduction will feature some 30+ talks covering all aspects of the biologics supply chain from automation and digital to downstream and upstream processing.
The first day discusses innovative technologies and latest machine trends that are driving the manufacturing of biologics, day two explores upstream manufacturing and day three looks at downstream and novel modalities.